JPS54117019A - Solublizing of insoluble medicine - Google Patents

Solublizing of insoluble medicine

Info

Publication number
JPS54117019A
JPS54117019A JP1441279A JP1441279A JPS54117019A JP S54117019 A JPS54117019 A JP S54117019A JP 1441279 A JP1441279 A JP 1441279A JP 1441279 A JP1441279 A JP 1441279A JP S54117019 A JPS54117019 A JP S54117019A
Authority
JP
Japan
Prior art keywords
solublizing
insoluble medicine
insoluble
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1441279A
Other languages
English (en)
Inventor
Arubaato Roo Pakuukan
Boun Uiriamuzu Jieemusu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JPS54117019A publication Critical patent/JPS54117019A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/609Amides, e.g. salicylamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP1441279A 1978-02-13 1979-02-13 Solublizing of insoluble medicine Pending JPS54117019A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/876,968 US4128632A (en) 1978-02-13 1978-02-13 Solubilization of Rafoxanide

Publications (1)

Publication Number Publication Date
JPS54117019A true JPS54117019A (en) 1979-09-11

Family

ID=25368975

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1441279A Pending JPS54117019A (en) 1978-02-13 1979-02-13 Solublizing of insoluble medicine

Country Status (18)

Country Link
US (1) US4128632A (ja)
EP (1) EP0003682B1 (ja)
JP (1) JPS54117019A (ja)
AR (1) AR221862A1 (ja)
AT (1) AT363600B (ja)
AU (1) AU522422B2 (ja)
DE (1) DE2962602D1 (ja)
DK (1) DK57479A (ja)
HU (1) HU177873B (ja)
IE (1) IE47833B1 (ja)
IT (1) IT1113720B (ja)
NZ (1) NZ189536A (ja)
OA (1) OA06239A (ja)
PH (1) PH13191A (ja)
PL (1) PL114317B1 (ja)
YU (1) YU25679A (ja)
ZA (1) ZA79597B (ja)
ZW (1) ZW3579A1 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2525108B1 (fr) * 1982-04-19 1989-05-12 Elan Corp Ltd Medicaments a haut degre de solubilite et procede pour leur obtention
YU43349B (en) * 1983-03-16 1989-06-30 Boehringer Ingelheim Ltd Process for making a watersoluble, pharmaceutically acceptible dispersion of chlortalidone in solid state
US4933360A (en) * 1983-03-16 1990-06-12 Boehringer Ingelheim Pharmaceuticals, Inc. Novel chlorthalidone process and product
WO1987006464A1 (en) * 1986-05-02 1987-11-05 Gaf Corporation Water soluble polyvinyl lactam-drug complexes
FR2640137A1 (fr) * 1988-12-08 1990-06-15 Texinfine Sa Systemes transporteurs de principes actifs lipophiles et leur procede d'obtention
EP1129713A1 (en) * 2000-02-29 2001-09-05 New Pharma Research Sweden AB Veterinary compositions for the treatment of parasitic diseases
GB2386066A (en) * 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
DE102010051404B4 (de) 2010-11-16 2017-08-31 Marc de Cocq Verwendung von substituierten Salicylaniliden zur Behandlung von Fischen
DE102012009572A1 (de) 2012-05-15 2013-11-21 Marc de Cocq Die Verwendung von Glycerol-Formal als Lösungsvermittler für pharmazeutische Wirkstoffe bei der Bekämpfung von Fischkrankheiten
CN106176586A (zh) * 2016-07-22 2016-12-07 柳州市柳南区安顺养殖协会 一种牛羊用抗寄生虫病碘醚柳胺透皮溶液

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5126212A (ja) * 1974-06-19 1976-03-04 Merck & Co Inc

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5126212A (ja) * 1974-06-19 1976-03-04 Merck & Co Inc

Also Published As

Publication number Publication date
NZ189536A (en) 1981-02-11
AT363600B (de) 1981-08-10
DK57479A (da) 1979-08-14
ATA106679A (de) 1981-01-15
PL114317B1 (en) 1981-01-31
PH13191A (en) 1980-01-16
OA06239A (fr) 1981-06-30
EP0003682B1 (en) 1982-04-28
ZW3579A1 (en) 1980-09-10
DE2962602D1 (en) 1982-06-09
YU25679A (en) 1984-02-29
HU177873B (en) 1982-01-28
IT1113720B (it) 1986-01-20
AU4391479A (en) 1979-08-23
ZA79597B (en) 1980-10-29
US4128632A (en) 1978-12-05
AU522422B2 (en) 1982-06-03
IE790259L (en) 1979-08-13
EP0003682A1 (en) 1979-08-22
AR221862A1 (es) 1981-03-31
PL213352A1 (ja) 1979-12-03
IT7947942A0 (it) 1979-02-08
IE47833B1 (en) 1984-06-27

Similar Documents

Publication Publication Date Title
GB2085732B (en) Administration set
JPS5540595A (en) Medicine inhaler
JPS54114494A (en) Preparation of phosgen
PH13717A (en) Recapsulation of nutrients
JPS55147223A (en) Pharmaceutical medicine
GB2016449A (en) Preparation of cis-alkylcyclohexanols
GB2078771B (en) Drug carrier
DE2964577D1 (en) Polymers of methyl-ethenyl-benzene
JPS55115866A (en) Allicinncyclodextrin contained complex and medicine
JPS54117019A (en) Solublizing of insoluble medicine
JPS54157817A (en) Pharmaceutical prepared solution
GB1550308A (en) Syringes
JPS54135483A (en) Ankle splint
JPS55392A (en) Muramyllpeptide type novel compounds and drug containing them
JPS5529584A (en) Polymerization of 11olefin
GB2039277B (en) Preparation of pharmacologically-active piperidylindoles
JPS54138116A (en) Medical constituent of mannentake
JPS54141797A (en) Therapeutic drug
PH15501A (en) Analogs of human bh-endorphin
JPS5529586A (en) Polymerization of 11olefin
DK173079A (da) Lynlaas
JPS54151992A (en) Alkoxycarbonyll33benzodiazepin novel derivatives*their manufacture and medicine containing them
JPS5497232A (en) Cultivation of horseeradish
GB2012590B (en) Syringe
JPS5562009A (en) Manufacture of ammoxysilinsodium medicine